Form 4 for ARCT Arcturus Therapeutics Holdings Inc.
Accepted 2022-12-19 00:00:00 ET · period of report 2022-12-15 · accession 0001193805-22-001748 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-12-19 | 2022-12-15 | ARCT | Marquet Magda | Dir | P - Purchase | $18.00 | +2,222 | 24.9K | +10% | +$40.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-15 | P | A | 2,222 | $18.00 | 24,942 | I Via Alma Life Sciences, LLC | — | — |